Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-15 Option Award | 2023-06-16 8:08 pm | N/A 2033-06-14 | Arcus Biosciences Inc. | RCUS | Lacey David L. Director | 26,300 | $0 | 68,752 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:07 pm | N/A 2023-06-12 | Atreca Inc. | BCEL | Lacey David L. Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-05-04 Option Award | 2023-05-04 7:57 pm | N/A 2033-05-03 | Nurix Therapeutics Inc. | NRIX | Lacey David L. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:23 pm | N/A 2032-06-13 | Arcus Biosciences Inc. | RCUS | Lacey David L. Director | 20,900 | $0 | 59,252 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 6:45 pm | N/A 2032-06-07 | Atreca Inc. | BCEL | Lacey David L. Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-06 5:40 pm | N/A 2032-05-04 | Nurix Therapeutics Inc. | NRIX | Lacey David L. Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:33 pm | N/A 2031-06-08 | Atreca Inc. | BCEL | Lacey David L. Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-07 4:38 pm | N/A 2031-06-02 | Arcus Biosciences Inc. | RCUS | Lacey David L. Director | 17,100 | $0 | 52,452 (Direct) | View |
| 2021-05-06 Option Award | 2021-05-24 7:49 pm | N/A 2031-05-05 | Nurix Therapeutics Inc. | NRIX | Lacey David L. Director | 17,500 | $0 | 17,500 (Direct) | View |
Ownership | 2020-07-23 6:52 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Lacey David L. Director | 0 | $0 | 99,999 (Direct) | View |
| 2020-06-18 Option Award | 2020-06-22 5:27 pm | N/A 2030-06-17 | Unity Biotechnology Inc. | UBX | Lacey David L. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-15 5:07 pm | N/A 2030-06-09 | Atreca Inc. | BCEL | Lacey David L. Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2020-05-21 Option Award | 2020-05-26 4:20 pm | N/A 2030-05-20 | Arcus Biosciences Inc. | RCUS | Lacey David L. Director | 50,000 | $0 | 50,000 (Direct) | View |
Ownership | 2020-05-26 4:18 pm | N/A N/A | Arcus Biosciences Inc. | RCUS | Lacey David L. Director | 0 | $0 | 40,352 (Direct) | View |
| 2019-06-20 Option Award | 2019-06-24 4:11 pm | N/A 2029-06-19 | Unity Biotechnology Inc. | UBX | Lacey David L. Director | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2019-06-19 5:17 pm | N/A 2026-07-19 | Atreca Inc. | BCEL | Lacey David L. Director | 0 | $0 | 54,532 (Direct) | View |